Lymphoma

Seattle Genetics: FDA Approves Adcetris to Treat Lymphomas

Adcetris is an antibody-drug that targets a type of lymphoma cell called CD30. It is the first treatment approved by the FDA for fighting Hodgkin lymphoma since 1977, and also the first made to specifically treat anaplastic large cell lymphoma.

Adcetris Gets FDA Approval to Treat 2 Types of Lymphoma

Adcetris is the first treatment for fighting Hodgkin lymphoma approved by the FDA since 1977, and the first specifically made to treat anaplastic large cell lymphoma. The drug is marketed by Seattle Genetics of Bothell, Wash.

Modified Ecstasy May Help Treat Cancer: Study

Researchers at the University of Birmingham have discovered that a modified version of Ecstasy (MDMA) may have great cancer-busting potential, fighting off myeloma, lymphoma, and leukemia.

Seattle Genetics: FDA Panel Endorses Lymphoma Drug

A government advisory panel unanimously approved an experimental drug, Adcetris, from Bothell, WA.-based drug maker, Seattle Genetics, serving as the company's first commercial drug approved by the U.S. Food and Drug Administration.

Pages